Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample
- PMID: 17040932
- PMCID: PMC2117062
- DOI: 10.1136/thx.2006.064410
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death worldwide. It is caused primarily by cigarette smoking. Given its importance, it is remarkable that reliable national prevalence data are lacking for most countries. This study provides estimates of the national prevalence of COPD in England, the extent of under-detection of the disorder, and patterns of cigarette smoking, dependence, and motivation to stop smoking in those with the disease.
Methods: Data from 8215 adults over the age of 35 who participated in the Health Survey for England were analysed. Information was obtained on self-reported and cotinine validated smoking status, cigarette dependence, motivation to stop smoking, COPD defined by spirometry using joint American Thoracic Society and European Respiratory Society criteria, and self-reports of diagnosis with respiratory disorders.
Results: Spirometry-defined COPD was present in 13.3% (95% CI 12.6 to 14.0) of participants, over 80% of whom reported no respiratory diagnosis. Even among people with severe or very severe COPD by spirometric assessment, only 46.8% (95% CI 39.1 to 54.6) reported any diagnosed respiratory disease. A total of 34.9% (95% CI 32.1 to 37.8) of people with spirometry-defined COPD were smokers compared with 22.4% (95% CI 21.4 to 23.4) of those without, and smoking prevalence increased with disease severity. Smokers with spirometry-defined COPD were more cigarette dependent but had no greater desire to quit than other smokers.
Conclusion: COPD is common among adults in England and is predominantly undiagnosed. In smokers it is associated with higher degrees of cigarette dependence but not with a greater motivation to stop smoking.
Conflict of interest statement
Competing interests: MJJ has accepted honoraria for speaking and travelling expenses from pharmaceutical companies making smoking cessation products. JB and RW have undertaken research and consultancy for companies developing and manufacturing smoking cessation medications. RW is also a co‐holder of a patent for a novel nicotine inhalation device.
Comment in
-
Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story.Thorax. 2006 Dec;61(12):1032-4. doi: 10.1136/thx.2006.067785. Thorax. 2006. PMID: 17114370 Free PMC article.
-
Diagnosis of COPD.Thorax. 2007 Oct;62(10):924-5; author reply 925. Thorax. 2007. PMID: 17909194 Free PMC article. No abstract available.
References
-
- Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 19973491498–1504. - PubMed
-
- Office for National Statistics Mortality statistics by cause. Series DH2 No. 30. London: The Stationery Office, 2004
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical